retatrutide peptide better than tirzepatide vs. π¬ Research Peptides Showdown: Retatrutide
Description
After the second or third year, discontinuation rates often decline
PMCID: PMC12353973
It can also lose lean muscle mass and bone density, which are critical for long-term strength and mobility
Exclusions apply, including an existing type 2 diabetes, obstructive sleep apnea, or MASH diagnosis
Our patients report improved confidence, better metabolic health, and sustainable weight management
